Literature DB >> 24907011

Acute promyelocytic leukemia.

Martin S Tallman1.   

Abstract

Entities:  

Mesh:

Year:  2014        PMID: 24907011     DOI: 10.1016/j.beha.2014.04.010

Source DB:  PubMed          Journal:  Best Pract Res Clin Haematol        ISSN: 1521-6926            Impact factor:   3.020


× No keyword cloud information.
  1 in total

1.  Sorafenib inhibited cell growth through the MEK/ERK signaling pathway in acute promyelocytic leukemia cells.

Authors:  Yunjie Zhang; Gangcan Li; Xin Liu; Yanping Song; Jia Xie; Guang Li; Jingjing Ren; Hao Wang; Jiao Mou; Jinqian Dai; Feng Liu; Liang Guo
Journal:  Oncol Lett       Date:  2018-02-09       Impact factor: 2.967

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.